AstraZeneca Confidently Pursues $80 Billion Revenue Target by 2030, Driven by New Medicines

AstraZeneca is forecasting steady profit growth and is confident in reaching its ambitious goal of $80 billion in annual sales by 2030, driven by new medicines and investments, despite challenges from US policies.